The DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.
Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men
Abstract
Background The intercellular adhesion molecule ICAM-1 mediates adhesion and transmigration of leucocytes to the vascular endothelial wall, a step proposed to be critical in the initiation and progression of atherosclerosis. Whether concentrations of soluble ICAM-1 (sICAM-1) are raised in apparently healthy individuals who later suffer acute myocardial infarction is unknown.Methods We obtained baseline plasma samples from a prospective cohort of 14,916 healthy men enrolled in the Physicians' Health Study. With a nested case-control design, we measured sICAM-1 concentrations for 474 participants who developed a first myocardial infarction, and 474 controls (participants who remained healthy throughout the 9-year follow-up). Cases were matched to controls according to age and smoking status at the time of myocardial infarction.Findings We found a significant association between increasing concentration of sICAM-1 and risk of future myocardial infarction (p = 0.003), especially among participants with baseline sICAM-1 concentrations in the highest quartile (> 260 ng/mL; relative risk 1.6 [95% Cl 1.1-2.4], p = 0.02). This association was present overall as well as among non-smokers, and persisted after control for lipid and non-lipid risk factors. In multivariate analyses, the risk of future myocardial infarction was 80% higher for participants with baseline sICAM-1 concentrations in the highest quartile (relative risk 1.8 [1.1-2.8], p = 0.02). Similar risk estimates were seen among non-smokers. We found slight but significant correlations between sICAM-1 and fibrinogen, high-density-lipoprotein cholesterol, homocysteine, triglycerides, tissue-type plasminogen-activator antigen, and C-relative protein, but adjustment for these altered the risk little. The risk of myocardial infarction associated with raised concentrations of sICAM-1 seemed to increase with length of follow-up.Interpretation Our data support the hypothesis that cellular mediators of inflammation have a role in atherogenesis and provide a clinical basis to consider antiadhesion therapies as a novel means of cardiovascular disease prevention.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“sICAM-1 has been shown to be associated with increased risk of future nonfatal cardiovascular events and incident diabetes. 37,38”
From Comprehensive Long-Term Changes in Cardiovascular Risk Biomarkers With Tirzepatide (2026) · cites this paper as [37]
Citations
Cites
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,618
Adhesion receptors of the immune system
Springer, T. A. (1990) · Nature · doi:10.1038/346425a0 · Cited by 6,477
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
Dustin, M. L., Rothlein, R., Bhan, A. K., Dinarello, C. A., & Springer, T. A. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.137.1.245 · Cited by 2,450
Final Report on the Aspirin Component of the Ongoing Physicians' Health Study
Steering Committee of the Physicians' Health Study Research Group (1989) · New England Journal of Medicine · doi:10.1056/nejm198907203210301 · Cited by 2,267
Molecular Bases of the Acute Coronary Syndromes
Libby, P. (1995) · Circulation · doi:10.1161/01.cir.91.11.2844 · Cited by 2,029
Endothelial Expression of a Mononuclear Leukocyte Adhesion Molecule During Atherogenesis
Cybulsky, M. I., & Gimbrone, M. A. (1991) · Science · doi:10.1126/science.1990440 · Cited by 1,710
Pober, J. S., Gimbrone, M. A., Lapierre, L. A., Mendrick, D. L., Fiers, W., Rothlein, R., & Springer, T. A. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.137.6.1893 · Cited by 1,413
Davies, M. J., Gordon, J. L., Gearing, A. J. H., Pigott, R., Woolf, N., Katz, D. R., & Kyriakopoulos, A. (1993) · The Journal of Pathology · doi:10.1002/path.1711710311 · Cited by 777
Pigott, R., Dillon, L. P., Hemingway, I., & Gearing, A. J. H. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)91234-h · Cited by 650
Cited by
Sorted by citations
Items 401–500 of 999
Demmer, E., Loan, M. D. V., Rivera, N., Rogers, T., Gertz, E., German, J. B., Smilowitz, J. T., & Zivkovic, A. M. (2016) · Journal of Nutritional Science · doi:10.1017/jns.2015.42 · Cited by 59
Endothelial dysfunctions: common denominators in vascular disease
Caterina, R. D. (2000) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/00075197-200011000-00007 · Cited by 57
Comite, G. D., Rossi, C. M., Marinosci, A., Lolmède, K., Baldissera, E. M., Aiello, P., Müeller, R. B., i, M. H., Voll, R. E., Rovere, P. Q., et al. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0608358 · Cited by 57
“In addition, data from experimental models and in vitro studies of human arteries support the notion that these molecules play important roles in atherosclerosis development [40–42].”
BackgroundHoward-Alpe, G. M., Sear, J. W., & Foëx, P. (2006) · British Journal of Anaesthesia · doi:10.1093/bja/ael303 · Cited by 57
In-Home Respite Intervention Reduces Plasma Epinephrine in Stressed Alzheimer Caregivers
Grant, I., McKibbin, C. L., Taylor, M. J., Mills, P. J., Dimsdale, J. E., Ziegler, M. G., & Patterson, T. L. (2003) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200301000-00009 · Cited by 57
C-Reactive Protein Increases Oxygen Radical Generation by Neutrophils
Prasad, K. (2004) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/107424840400900308 · Cited by 57
Lim, S. C., Caballero, A. E., Arora, S., Smakowski, P., Bashoff, E. M., Brown, F. M., LoGerfo, F. W., Horton, E. S., & Veves, A. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.11.6160 · Cited by 57
Type 2 diabetes mellitus: a cardiovascular perspective
Varughese, G. I., Tomson, J., & Lip, G. Y. H. (2005) · International Journal of Clinical Practice · doi:10.1111/j.1368-5031.2005.00571.x · Cited by 57
Signals mediating cleavage of intercellular adhesion molecule-1
Tsakadze, N. L., Sen, U., Zhao, Z., Sithu, S. D., English, W., & D’Souza, S. E. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00585.2003 · Cited by 56
“Elevated levels of sICAM-1 predict a risk of cardiovascular disease (31, 43).”
BackgroundLabarrere, C. A., Nelson, D. R., Miller, S. J., Nieto, J. M., Conner, J. A., Pitts, D. E., Kirlin, P. C., & Halbrook, H. G. (2000) · Circulation · doi:10.1161/01.cir.102.13.1549 · Cited by 56
Markers of Hemostasis and Systemic Inflammation in Heart Disease and Atherosclerosis in Smokers
MacCallum, P. K. (2005) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200406-036ms · Cited by 55
Adhesion molecules and cardiovascular risk in peripheral arterial disease
Schiano, V., Scopacasa, F., Massimo Chiariello, A., Silvestro, A., & Brevetti, G. (2005) · Thrombosis and Haemostasis · doi:10.1160/th04-07-0440 · Cited by 55
“Several large cohort studies show that sICAM-1 is a better prognostic indicator in healthy individuals (5, 6), whereas sVCAM-1, rather than sICAM-1, was found to be a predictor of cardiovascular events in patients with manifest atherosclerotic disease (7, 8).”
BackgroundTousoulis, D., Oikonomou, E. K., Siasos, G., Chrysohoou, C. A., Zaromitidou, M., Kioufis, S., Maniatis, K., Dilaveris, P., Miliou, A., Michalea, S., et al. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.01.015 · Cited by 55
“Except from their central role in atherogenesis, adhesion molecules are also elevated in states of ischemic and dilated cardiomyopathy [19] and are associated with increased cardiovascular events [20].”
BackgroundJenny, N. S., Arnold, A. M., Kuller, L. H., Sharrett, A. R., Fried, L. P., Psaty, B. M., & Tracy, R. P. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01678.x · Cited by 55
Seçkin, D., İlhan, A., İlhan, N., & Ertuğrul, S. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.01.001 · Cited by 55
Serum markers of vascular inflammation in dyslipemia
Francisco, G., Hernández, C., & Simó, R. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2005.12.027 · Cited by 54
Biomarcadores en la medicina cardiovascular
Martı́n-Ventura, J. L., Blanco‐Colio, L. M., Tuñón, J., Muñoz‐García, B., Madrigal‐Matute, J., Moreno, J. A., de Céniga, M. V., & Egido, J. (2009) · Revista Española de Cardiología · doi:10.1016/s0300-8932(09)71335-1 · Cited by 55
Kiecolt-Glaser, J. K., Fagundes, C. P., Andridge, R., Peng, J., Malarkey, W. B., Habash, D., & Belury, M. A. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.149 · Cited by 54
Endothelial microparticles correlate with erectile dysfunction in diabetic men
Esposito, K., Ciotola, M., Giugliano, F. M., Schisano, B., Improta, L., Improta, M. R., Beneduce, F., Rispoli, M., SIO, M. D., & Giugliano, D. (2006) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3901500 · Cited by 54
Recent advances in vascular inflammation: C-reactive protein and other inflammatory biomarkers
Maksimowicz‐McKinnon, K., Bhatt, D. L., & Calabrese, L. H. (2003) · Current Opinion in Rheumatology · doi:10.1097/00002281-200401000-00005 · Cited by 54
Heritability and correlates of intercellular adhesion molecule-1 in the Framingham Offspring Study
Keaney, J. F., Massaro, J. M., Larson, M. G., Vasan, R. S., Wilson, P. W. F., Lipinska, I., Corey, D., Sutherland, P. A., Vita, J. A., & Benjamin, E. J. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.03.048 · Cited by 54
Hillis, G. S., Terregino, C., Taggart, P., Killian, A. J., Zhao, N., Dalsey, W. C., & Mangione, A. (2002) · American Heart Journal · doi:10.1067/mhj.2002.120303 · Cited by 54
Heilman, K., Zilmer, M., Zilmer, K., Kool, P., & Tillmann, V. (2008) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510802419454 · Cited by 53
“ADMA was determined in plasma using a validated ELISA kit (DLD Gesellschaft für Diagnostika und Medizi-nische Geräte mbH; Hamburg), ICAM-1 using human soluble ICAM-1 CD54 immunoassay (R&D Systems Europe, UK), tHcy using an Axis Homocysteine EIA kit (Axis-Shield Diagnostics Ltd, UK), adiponectin using Human Adiponect…”
BackgroundInfluentialKvasnička, J., Marek, J., Kvasnička, T., Weiss, V., Marková, M., Stepan, J. J., & Umlaufová, A. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.01002.x · Cited by 53
“…alpha-1-acid glycoprotein), and of soluble adhesion molecules E-selectin, P-selectin and ICAM-1 (intercellular adhesion molecule-1), increased levels of which are found in cardiovascular disease of atherosclerotic origin (Held et al., 1997; Ridker, 1997; Ridker et al., 1998; Lindberg et al., 1999).”
BackgroundHolmlund, A., Hédin, M., Pussinen, P. J., Lerner, U. H., & Lind, L. (2009) · International Journal of Cardiology · doi:10.1016/j.ijcard.2009.10.034 · Cited by 53
Relation Between Soluble Adhesion Molecules and Insulin Sensitivity in Type 2 Diabetic Individuals
Targher, G., Bonadonna, R. C., Alberiche, M., Zenere, M. B., Muggeo, M., & Bonora, E. (2001) · Diabetes Care · doi:10.2337/diacare.24.11.1961 · Cited by 54
“Accordingly, increased plasma concentrations of intercellular adhesion molecule (ICAM)-1 and P-selectin independently predicted myocardial infarction in healthy individuals (4,5).”
BackgroundBlann, A. D., Gurney, D. A., Hughes, E. A., Buggins, P., Silverman, S., & Lip, G. Y. H. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01597-1 · Cited by 53
Ethnic differences in circulating soluble adhesion molecules: the Wandsworth Heart and Stroke Study
Miller, M. A., Sagnella, G. A., Kerry, S., Strazzullo, P., Cook, D. G., & Cappuccio, F. P. (2003) · Clinical Science · doi:10.1042/cs20020333 · Cited by 53
Sordillo, L. M., Streicher, K. L., Kanevsky, I., Gandy, J. C., Trigona, W. L., & Corl, C. M. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.09.002 · Cited by 52
“A positive correlation exists between soluble ICAM-1 expression and the degree of atherosclerosis and some suggest that ICAM-1 could be a predictor of future cardiovascular events [3].”
BackgroundSaetre, T., Enoksen, E. J., Lyberg, T., Stranden, E., Jorgensen, J. J., Sundhagen, J. O., & Hisdal, J. (2011) · Angiology · doi:10.1177/0003319710385338 · Cited by 52
Autoimmune atherosclerosis in 3D: How it develops, how to diagnose and what to do
Szekanecz, Z., Kerekes, G., Végh, E., Kardos, Z., Baráth, Z., Tamási, L., & Shoenfeld, Y. (2016) · Autoimmunity Reviews · doi:10.1016/j.autrev.2016.03.014 · Cited by 52
Methods of Endothelial Function Assessment: Description and Applications
Storch, A. S., Mattos, J. D., Alves, R., Galdino, I. D. S., & Rocha, H. N. M. (2017) · International Journal of Cardiovascular Sciences · doi:10.5935/2359-4802.20170034 · Cited by 52
Soluble adhesion molecules in acute ischemic stroke.
Šimundić, A.-M., Bašić, V., Topić, E., Demarin, V., Vrkić, N., Kunović, B., Štefanović, M., & Begonja, A. J. (2004) · PubMed · Cited by 52
Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration
Evans, J. R., & Henshaw, K. S. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000253.pub2 · Cited by 53
Musso, G., Bo, S., Cassader, M., Michieli, F. D., & Gambino, R. (2013) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.063792 · Cited by 53
Lind, P., Engström, G., Stavenow, L., Janzon, L., Lindgärde, F., & Hedblad, B. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000116863.37311.82 · Cited by 51
Musso, G., Cipolla, U., Cassader, M., Pinach, S., Saba, F., Michieli, F. D., Paschetta, E., Bongiovanni, D., Framarin, L., Leone, N., et al. (2017) · Journal of Lipid Research · doi:10.1194/jlr.m075028 · Cited by 51
“frequently-sampled intravenous glucose tolerance test (FIVGTT) in NAFLD and in nondiabetic subjects[21,25] and reliably predict T2DM development[26].”
BackgroundMethodProtective Effects of Polyphenols against Ischemia/Reperfusion Injury
Cebová, M., & Pecháňová, O. (2020) · Molecules · doi:10.3390/molecules25153469 · Cited by 53
Bemelmans, W. J., Lefrandt, J., Feskens, E., Broer, J., Tervaert, J., May, J., & Smit, A. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00747-x · Cited by 88
Herron, B. J., Rao, C., Liu, S., Laprade, L., Richardson, J. A., Olivieri, E. R., Semsarian, C., Millar, S. E., Stubbs, L. J., & Beier, D. R. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi063 · Cited by 50
Morning levels of fibrinogen in children with sleep-disordered breathing
Kaditis, A. G., Alexopoulos, E. Ι., Kalampouka, E., Kostadima, E., Angelopoulos, N. V., Germenis, A. E., Zintzaras, E., & Gourgoulianis, K. I. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00009804 · Cited by 51
Effect of losartan in aging-related endothelial impairment
Rajagopalan, S., Brook, R. D., Mehta, R. H., Supiano, M. A., & Pitt, B. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)02297-4 · Cited by 51
Devaraj, S., Cabo-Chan, A. V., & Jialal, I. (2002) · Diabetes Care · doi:10.2337/diacare.25.3.524 · Cited by 50
Biomarkers in Cardiovascular Medicine
Martı́n-Ventura, J. L., Blanco‐Colio, L. M., Tuñón, J., Muñoz‐García, B., Madrigal‐Matute, J., Moreno, J. A., de Céniga, M. V., & Egido, J. (2009) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(09)72232-7 · Cited by 50
“In healthy populations, the intercellular adhesion molecule-1 (ICAM-1) reaches greater concentrations in healthy subjects who will undergo acute myocardial infarction (AMI), whereas data suggest this is not the case regarding the vascular cell adhesion molecule-1 (VCAM-1).(4,5) The ARIC (Atherosclerosis in Risk Commun…”
BackgroundHoogeveen, R. C., Ballantyne, C. M., Bang, H., HEISS, G. M., Duncan, B. B., Folsom, A. R., & Pankow, J. S. (2006) · Diabetologia · doi:10.1007/s00125-006-0533-8 · Cited by 50
“In several studies, we and others have shown that circulating ICAM-1 may serve as a molecular marker for atherosclerosis and development of CHD [14–16].”
Effect of simvastatin on monocyte adhesion molecule expression in patients with hypercholesterolemia
Junior, C. V. S., Yoshida, V. M., Venturinelli, M. L., D’Amico, É. A., Monteiro, H. P., Ramires, J. A. F., & da Luz, P. L. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00757-7 · Cited by 50
“Soluble endothelial cell adhesion molecules, such as sICAM-1, vascular cell adhesion molecule (sVCAM)-1, and sE-selectin, have been found to be elevated in patients with dyslipidemia, and it has been proposed that soluble cell adhesion molecules may represent a marker of endothelial atherosclerotic damage [27, 28 ].”
BackgroundBodard, Q., Langlois, V., Guilpain, P., Quellec, A. L., Vittecoq, O., Noel, D., Eble, V., Josse, S., Schmidt, J., Aouba, A., et al. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102541 · Cited by 49
Kluft, C., & de Maat, M. P. M. (2002) · Vascular Pharmacology · doi:10.1016/s1537-1891(02)00293-8 · Cited by 49
Empen, K., Otto, C., Brödl, U. C., & Parhofer, K. G. (2002) · Journal of Clinical Apheresis · doi:10.1002/jca.10010 · Cited by 49
Marketou, M. E., Zacharis, E. A., Nikitovic, D., Ganotakis, E. S., Parthenakis, F. I., Maliaraki, N. E., & Vardas, P. E. (2006) · Angiology · doi:10.1177/000331970605700212 · Cited by 49
The influence of tobacco smoking on adhesion molecule profiles
Scott, D. A., & Palmer, R. (2003) · Tobacco Induced Diseases · doi:10.1186/1617-9625-1-1-7 · Cited by 49
“Therefore smokers will be more likely to be in the upper quartile of sICAM-1 levels, where increased risk of vascular disease is most evident [146].”
Oxidative stress, alpha-tocopherol therapy, and atherosclerosis
Harris, A., Devaraj, S., & Jialal, I. (2002) · Current Atherosclerosis Reports · doi:10.1007/s11883-002-0075-6 · Cited by 48
Increased levels of markers of vascular inflammation in patients with coronary heart disease
Schumacher, A., Seljeflot, I., Sommervoll, L., Christensen, B., Otterstad, J. E., & Arnesen, H. (2002) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/003655102753517217 · Cited by 48
Neopterin induces pro‐atherothrombotic phenotype in human coronary endothelial cells
Cirillo, P. L., Pacileo, M., Rosa, S. D., Calabrò, P., Gargiulo, A., Angri, V., GRANATO‐CORIGLIANO, F., Fiorentino, I., Prevete, N., Palma, R. D., et al. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.02125.x · Cited by 47
Blann, A. D., Farrell, A., Picton, A., & McCollum, C. N. (2000) · Thrombosis Research · doi:10.1016/s0049-3848(99)00156-5 · Cited by 48
Arsenic Exposure and Subclinical Endpoints of Cardiovascular Disease
Wu, F., Molinaro, P. F., & Chen, Y. (2014) · Current Environmental Health Reports · doi:10.1007/s40572-014-0011-2 · Cited by 47
Parissis, J., Venetsanou, K. F., Mentzikof, D. G., Kalantzi, M. V., Georgopoulou, M., Chrisopoulos, N., & Karas, S. M. (2001) · European Journal of Internal Medicine · doi:10.1016/s0953-6205(01)00125-x · Cited by 47
Canales, A., Sánchez-Muniz, F. J., Bastida, S., Librelotto, J., Nus, M., Corella, D., Guillén, M., & Benedı́, J. (2011) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2011.20 · Cited by 47
“elevated sICAM-1 levels may be a marker for coronary heart disease (CHD) risk and atherosclerosis (Hwang et al., 1997; Peter et al., 1997; Ridker et al., 1998; Blann and Lip, 2000; Blankenberg et al., 2001).”
BackgroundInfluentialMenown, I. B. A., Mathew, T. P., Gracey, H., Nesbitt, G. S., Murray, P., Young, I. S., & Adgey, A. A. J. (2003) · American Heart Journal · doi:10.1016/s0002-8703(03)00169-8 · Cited by 47
Effects of perceived stress and uplifts on inflammation and coagulability
Jain, S., Mills, P. J., von Känel, R., Hong, S., & Dimsdale, J. E. (2006) · Psychophysiology · doi:10.1111/j.1469-8986.2006.00480.x · Cited by 47
Nora, E. D., Passaro, A., Zamboni, P., Calzoni, F., Fellin, R., & Solini, A. (2003) · Journal of Endocrinological Investigation · doi:10.1007/bf03345126 · Cited by 47
The effect of alcohol consumption on endothelial adhesion molecule expression
Sacanella, E., & Estruch, R. (2003) · Addiction Biology · doi:10.1080/13556210310001656376 · Cited by 47
“In fact, this latter application has already been used in large epidemiological studies with good correlations.(30,32,45) However, it would”
MethodGene-Centric Meta-Analysis of Lipid Traits in African, East Asian and Hispanic Populations
Elbers, C. C., Guo, Y., Tragante, V., van Iperen, E. P. A., Lanktree, M. B., Castillo, B. A., Chen, F., Yanek, L. R., Wojczynski, M. K., Li, Y. R., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050198 · Cited by 47
“sICAM1 has been associated with several common diseases such as diabetes, heart disease, stroke, and malaria [46,47].”
BackgroundContribution of insulin resistance to vascular dysfunction
Anfossi, G., Russo, I., Doronzo, G., & Trovati, M. (2009) · Archives of Physiology and Biochemistry · doi:10.1080/13813450903136791 · Cited by 49
“, 1998), as well as an increase of circulating levels of specific markers of endothelial activation, such as von Willebrand factor, thrombomodulin, E-selectin, P-selectin, soluble ICAM (sICAM) and soluble VCAM-1 (sVCAM) (Hwang et al., 1997; Cosentino & Luscher, 1998; Ridker et al., 1998; Malik et al., 2001).”
BackgroundMadore, F. (2003) · Seminars in Dialysis · doi:10.1046/j.1525-139x.2003.16031.x · Cited by 47
Halvorsen, B. L., Sagen, E. L., Ueland, T., Aukrust, P., & Tonstad, S. (2007) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510701283878 · Cited by 46
“There is also accumulating evidence from prospective studies showing that circulating levels of sICAM-1 can predict CAD events in initially healthy people as well as in patients at high risk or with overt CAD [13].”
BackgroundConnecting the role of C-reactive protein and statins in cardiovascular disease
Ridker, P. M. (2003) · Clinical Cardiology · doi:10.1002/clc.4960261508 · Cited by 46
Mueck, A. O., Seeger, H., & Wallwiener, D. R. (2002) · Menopause The Journal of The North American Menopause Society · doi:10.1097/00042192-200207000-00008 · Cited by 46
“showed that a soluble form of adhesion molecules can be measured in the serum.(21) Evidence is growing that they emerge from shedding of membrane-associated adhesion molecules and thus indirectly reflect the expression of adhesion molecules on endothelial cells.”
BackgroundArnesen, H., Hofstad, A.-E., Os, I., & Seljeflot, I. (2000) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613947 · Cited by 46
“In addition, an association between plasma levels of soluble ICAMs and risk for future myocardial infarction in healthy men, was recently reported (18).”
BackgroundRojas‐Villarraga, A., Ortega‐Hernandez, O., Gómez, L. F., Pardo, A. L., López-Guzmán, S., Arango-Ferreira, C., Zapata, M. E. H., Betancur, J. F., Pineda-Tamayo, R. A., Díaz, F. J., et al. (2008) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2008.01.019 · Cited by 45
Rubin, D., Claas, S., Pfeuffer, M., Nothnagel, M., Fölsch, U. R., & Schrezenmeir, J. (2008) · Lipids in Health and Disease · doi:10.1186/1476-511x-7-32 · Cited by 45
“In contrast, Ridker et al. [ 9 ] found a slight but significant correlation between sICAM-1 and fasting triglycerides in patients with risk for future myocardial infarction.”
Larson, N. B., Bell, E. J., Decker, P. A., Pike, M., Wassel, C. L., Tsai, M. Y., Pankow, J. S., Tang, W., Hanson, N. Q., Alexander, K., et al. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.05.049 · Cited by 45
“Soluble forms of CAMs Eselectin (sE-Selectin), P-selectin (sP-selectin), and ICAM-1 (sICAM1) are biomarkers of inflammation, and increased circulation with one or more of these markers has been associated with coronary artery disease [12], myocardial infarction [13] and atherosclerosis [14e16].”
BackgroundElevated soluble ICAM‐1 levels induce immune deficiency and increase adiposity in mice
Wang, H., Babic, A. M., Mitchell, H. A., Liu, K., & Wagner, D. D. (2005) · The FASEB Journal · doi:10.1096/fj.04-3094fje · Cited by 45
“In inflammation, sICAM-1 levels reflect endothelial cell activation, and indeed there is increasing evidence that patients with high levels of sICAM-1 are at risk for cardiovascular disease (12, 13).”
BackgroundJilma, B., Li‐Saw‐Hee, F. L., Wagner, O. F., Beevers, D. G., & Lip, G. Y. H. (2002) · Clinical Science · doi:10.1042/cs1030131 · Cited by 45
Cellular adhesion molecules and peripheral arterial disease
Brevetti, G., Schiano, V., & Massimo Chiariello, A. (2006) · Vascular Medicine · doi:10.1191/1358863x06vm645ra · Cited by 44
HIV , highly active antiretroviral therapy and the heart: a cellular to epidemiological review
Lambert, C., Sandesara, P. B., Hirsh, B. J., Shaw, L. J., Lewis, W., Quyyumi, A. A., Schinazi, R., Post, W. S., & Sperling, L. S. (2015) · HIV Medicine · doi:10.1111/hiv.12346 · Cited by 44
“…are underway as to whether contributors [soluble intercellular adhesion molecules (sICAMs), tissue plasminogen activator molecules (t-PAs) and plasminogen activator inhibitor (PAI-1)] to this “dysfunction cascade” could be used as biomarkers to more reliably predict risk [61,62,109–113].”
Tang, W., Pankow, J. S., Carr, J. J., Tracy, R. P., Bielinski, S. J., North, K. E., Hopkins, P. N., Kraja, A. T., & Arnett, D. K. (2007) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-7-30 · Cited by 44
“Prospective epidemiological studies have found increased risk of incident or recurrent coronary heart disease (CHD) associated with higher baseline levels of sICAM-1 and MCP-1 [15-18], but it is unclear whether sICAM-1 and MCP-1 reflect the burden of subclinical coronary atherosclerosis.”
The potential anti-inflammatory benefits of improving physical fitness in hypertension
Edwards, K. M., Ziegler, M. G., & Mills, P. J. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e328165ca67 · Cited by 43
Palmer, R. M. J., Stapleton, J., Sutherland, G., Coward, P. Y., Wilson, R. F., & Scott, D. A. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.01067.x · Cited by 44
Paik, J. K., Kim, O. Y., Koh, S. J., Jang, Y., Chae, J. S., Kim, J. Y., Kim, H. J., Hyun, Y. J., Cho, J. R., & Lee, J. H. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2006.11.011 · Cited by 44
Garbin, U., Pasini, A. F., Stranieri, C., Manfro, S., Mozzini, C., Boccioletti, V., Pasini, A., Cominacini, M., Evangelista, S., & Cominacini, L. (2008) · Mediators of Inflammation · doi:10.1155/2008/367590 · Cited by 44
“Several studies have reported increased plasma levels of E-selectin and ICAM-1 in patients with hypertension, diabetes, and hypercholesterolemia [25– 28]; moreover in patients at cardiovascular risk, plasma concentration of ICAM-1 can predict adverse outcome [27, 28].”
BackgroundSchumacher, A., Peersen, K., Sommervoll, L., Seljeflot, I., Arnesen, H., & Otterstad, J. E. (2006) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/01.hjr.0000188244.54287.96 · Cited by 44
McNair, E. D., Wells, C. R., Qureshi, A. M., Basran, R., Pearce, C., Orvold, J., Devilliers, J., & Prasad, K. (2010) · Clinical Cardiology · doi:10.1002/clc.20815 · Cited by 44
Diagnostic value of CRP and Lp(a) in coronary heart disease
Erbağcı, A. B., Tarakçıoğlu, M., Aksoy, M. F., Kocabaş, R., Nacak, M., Aynacıoğlu, A. Ş., & Sivrikoz, C. (2002) · Acta Cardiologica · doi:10.2143/ac.57.3.2005389 · Cited by 44
Combined hormone replacement therapy improves endothelial function in healthy postmenopausal women
Gužič‐Salobir, B., Keber, I., Seljeflot, I., Arnesen, H., & Dežman, L. V. (2001) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2001.00910.x · Cited by 44
Scott, D. A., Stapleton, J., Wilson, R. F., Sutherland, G., Palmer, R. M. J., Coward, P. Y., & GUSTAVSSON, G. (2000) · Blood Cells Molecules and Diseases · doi:10.1006/bcmd.2000.0304 · Cited by 44
The mechanisms of thrombotic risk induced by hormone replacement therapy
Cano, A., & van Baal, W. M. (2001) · Maturitas · doi:10.1016/s0378-5122(01)00270-5 · Cited by 44
“[175] Ridker PM, Hennekens CH, Roitman-Johnson B,”
BackgroundHolmlund, A., Hulthe, J., Millgård, J., Sarabi, M., Kahan, T., & Lind, L. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(02)00234-4 · Cited by 44
Is Type 2 Diabetes Mellitus a Vascular Condition?
Hu, F. B., & Stampfer, M. J. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000094360.38911.71 · Cited by 44
Circulating adhesion molecules in obstructive sleep apnea and cardiovascular disease
Pak, V. M., Grandner, M. A., & Pack, A. I. (2014) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2013.01.002 · Cited by 43
Role of environmental toxicants in the development of hypertensive and cardiovascular diseases
Habeeb, E. A., Aldosari, S. A., Saghir, S. A., Cheema, M., Momenah, T., Husain, K. M., Omidi, Y., Rizvi, S. A. A., Akram, M., & Ansari, R. A. (2022) · Toxicology Reports · doi:10.1016/j.toxrep.2022.03.019 · Cited by 50
“A positive association between long-term well-water As exposure and plasma levels of soluble ICAM-1 and soluble VCAM-1 (biomarkers to predict future CVD), biomarkers of endothelial dysfunction, and vascular inflammation is observed in an As-exposed population of Araihazar, Bangladesh [15,155,37].”
BackgroundMechanisms of action for arsenic in cardiovascular toxicity and implications for risk assessment
Sidhu, M. S., Desai, K. P., Lynch, H. N., Rhomberg, L. R., Beck, B. D., & Venditti, F. J. (2015) · Toxicology · doi:10.1016/j.tox.2015.02.008 · Cited by 43
“…iAs-related skin lesions in Bangladesh, there was a positive association with plasma levels of soluble ICAM-I (sICAM-1) and soluble VCAM-1 (sVCAM-1) (Chen et al., 2007b), markers indicative of potential development of CVD (Blankenberg et al., 2001; Ridker et al., 1998, 2000; States et al., 2009).”
BackgroundTretjakovs, P., Jurka, A., Bormane, I., Miķelsone, I., Elksne, K., Krieviņa, G., Reihmane, D., Verbovenko, J., & Bahs, G. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.10.009 · Cited by 43
Rohatgi, A. K., Owens, A. W., Khera, A., Ayers, C. R., Banks, K., Das, S. R., Berry, J. D., McGuire, D. K., & de Lemos, J. A. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.190553 · Cited by 43
Schmidt, C. B., Hulthe, J., & Fagerberg, B. (2008) · Angiology · doi:10.1177/0003319708316899 · Cited by 43
“In contrast to data on baseline levels of ICAM-1, no evidence of an association between baseline VCAM-1 levels and risk of future cardiovascular events has been shown.(7,8) Introduction”
ResultMultiple inflammatory markers in patients with significant coronary artery disease
Videm, V., Wiseth, R., Gunnes, S., MADSEN, H. O., & Garred, P. (2006) · International Journal of Cardiology · doi:10.1016/j.ijcard.2006.07.005 · Cited by 43
“Different markers of endothelial activation have been related to atherosclerosis and/or future risk of cardiovascular events [17–19].”
BackgroundEffects of Transdermal Estrogen Replacement Therapy on Cardiovascular Risk Factors
Menon, D. V., & Vongpatanasin, W. (2006) · Treatments in Endocrinology · doi:10.2165/00024677-200605010-00005 · Cited by 42
Labarrere, C. A., Nelson, D. R., & Park, J.-W. (2001) · Current Opinion in Cardiology · doi:10.1097/00001573-200103000-00006 · Cited by 43
Mechanisms of Arsenic Exposure-Induced Hypertension and Atherosclerosis: an Updated Overview
Balarastaghi, S., Rezaee, R., Hayes, A. W., Yarmohammadi, F., & Karimi, G. (2022) · Biological Trace Element Research · doi:10.1007/s12011-022-03153-2 · Cited by 41
“plasma concentration of sICAM-1 and the risk of cardiovascular diseases [105], including myocardial infarction [106] and carotid artery atherosclerosis [107].”
BackgroundRoed, T., Kristoffersen, U. S., Knudsen, A. D., Wiinberg, N., Lebech, A., Almdal, T., Thomsen, R. W., Kjær, A., & Weis, N. M. (2014) · Vascular Health and Risk Management · doi:10.2147/vhrm.s53557 · Cited by 42
Metadata
- Authors
- Ridker, P. M., Hennekens, C. H., Roitman-Johnson, B., Stampfer, M. J., & Allen, J.
- Affiliations
- Brigham and Women's Hospital (US)
- R&D Systems (United States) (US)
- Corresponding author
- Ridker, Paul M
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 1998-01
- Volume
- 351
- Issue
- 9096
- Pages
- 88-92
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2138809584
- Cited by
- 1,229
- References
- 35
- Citations by year
- 2026: 7 · 2025: 10 · 2024: 8 · 2023: 10 · 2022: 16 · 2021: 16 · 2020: 17 · 2019: 23 · 2018: 14 · 2017: 28 · 2016: 27 · 2015: 25 · 2014: 38 · 2013: 27 · 2012: 36
- FWCI
- 26.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
- Keywords
- soluble intercellular adhesion molecule-1, sICAM-1, myocardial infarction, atherosclerosis, inflammation, endothelial cell adhesion, anti-adhesion therapy, cardiovascular risk, fibrinogen, homocysteine, tissue plasminogen activator, C-reactive protein, healthy men, Physicians' Health Study
- MeSH terms
- Antioxidants, Arteriosclerosis, Aspirin, Double-Blind Method, Humans, Male, Middle Aged, Myocardial Infarction, Platelet Aggregation Inhibitors, Prospective Studies, Risk Factors, Multivariate Analysis, Case-Control Studies, Intercellular Adhesion Molecule-1, beta Carotene
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review